In 2013, TeamConnor Childhood Cancer Foundation awarded Dr. Barbieri of Baylor College of Medicine, Texas Children’s Hospital in Houston $75,254 for her research in neuroblastoma. To date, her research in this area has shown encouraging results.
She has determined that a specific protein in neuroblastoma cells, CHAF1, is an epigenetic regulator which controls the metabolism of many aggressive neuroblastoma tumors, by way of altered gene expression.
Dr. Barbieri’s laboratory research has great potential and the information she has determined may allow for new therapies targeting CHAF1 in neuroblastoma for better patient outcomes.
TeamConnor is pleased to have supported her work which produced this potential advancement in neuroblastoma treatment.
You must be logged in to post a comment.
Sign up to comment in the forums, on posts, and receive our newsletters.